• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Thrombosis (2100)
Event Date 05/08/2012
Event Type  Injury  
Manufacturer Narrative
As it is unknown which device(s) may have contributed to the thrombosis, an additional gore® viabahn® endoprosthesis devices have been included in this report: (lot number unknown and udi unknown).
 
Event Description
The following literature article was reviewed: "overcoming challenges of endovascular treatment of complex subclavian and axillary artery injuries in hypotensive patients" ramyar gilani, md et at.Journal of trauma acute care surgery volume 73, number 3 submitted: february 21, 2012; revised: may 6, 2012; accepted: may 8, 2012.Method: from (b)(6) 2010, to (b)(6) 2011, patients who presented to (b)(6)hospital in (b)(6) with subclavian or axillary artery injuries were taken to a trauma operating room equipped with a mobile c-arm and fluoroscopic bed for attempted endovascular repair of their injuries.After repair, patients were followed up both clinically and by serial vascular ultrasound as surveillance.Patients were tracked prospectively through a vascular trauma database.Results: a total of eight consecutive patients with subclavian and axillary artery injuries underwent endovascular repair with the use of the previously described technique.There were no iatrogenic injuries represented in this patient group.The sample group includes all patients with subclavian and axillary injuries that presented to (b)(6) hospital during the sample period, and no patient underwent open repair during the period.No 30-day mortality or femoral or brachial access site complications.No patient required venous intervention.The 1-year primary patency was 100 percent.However, there was one late graft thrombosis at 14 months for the patient (number 6) with two gore® viabahn® endoprostheses placed.This remained asymptomatic, and no further intervention has been required.No graft infections have been reported to date.
 
Manufacturer Narrative
Added method code 2 - device disposition.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key10022832
MDR Text Key194522006
Report Number2017233-2020-00310
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup
Report Date 07/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/04/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age66 YR
-
-